(Q43937952)

English

31Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

31Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Peter Hohenberger

5

object named as

Peter Hohenberger

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Christoph Kettelhack

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Minette v Wickede

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Thomas Vogl

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ulrike Schneider

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

94

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1557-1564

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Clinical management and current research in isolated limb perfusion for sarcoma and melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

[Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Dynamic contrast-enhanced MRI with subtraction of aggressive soft tissue tumors after resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Impact of hyperthermic regional perfusion therapy on cell metabolism of malignant melanoma monitored by 31P MR spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Monitoring human tumor response to therapy by means of P-31 MR spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

31P magnetic resonance spectroscopy as predictor of clinical response in human extremity sarcomas treated by single dose TNF-alpha + melphalan isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Response of a non-Hodgkin lymphoma to 60Co therapy monitored by 31P MRS in situ

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

31P-NMR studies of a human tumour in situ

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Extremity bone tumors: evaluation by P-31 MR spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Osteosarcoma and other neoplasms of bone. Magnetic resonance spectroscopy to monitor therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

31P MRS as an early prognostic indicator of patient response to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

31P NMR spectra of extremity sarcomas: diversity of metabolic profiles and changes in response to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10361

21 January 2018

Identifiers

10.1002/CNCR.10361

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43937952&oldid=2104516768"